Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2001
02/13/2001US6187572 Decontaminating blood and cell cultures by mixing with a chemical radiation sensitizer which does not bind to the membrane, freezing or freeze-drying the mixture, then exposing to electromagnetic radiation
02/13/2001US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents
02/13/2001US6187563 βIV-spectrin-polypeptides and nucleic acids encoding same
02/13/2001US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents
02/13/2001US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects
02/13/2001US6187558 Nucleotide sequence coding enzymatic protein; for development of efficient pesticides in transgenic plants
02/13/2001US6187557 Nucleotide sequences coding modulator protein; for the diagnosis and treatment of defects in apotosis
02/13/2001US6187552 Screening for enzyme inhibitors; incubating two preferential proteins with modulator, detect whether modulator prevents formation of complex between preferential proteins
02/13/2001US6187548 Detecting modulators of a human receptor polypeptide; expressing receptor polypeptide in cell, incubating modulator with cell expressing receptor polypeptide, monitor modulating activity
02/13/2001US6187543 Method of screening a compound for its ability to enhance the ability of tristetraprolin to inhibit tumor necrosis factor
02/13/2001US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders
02/13/2001US6187321 A diagnostic kit for detecting the presence of antibodies in a biological sample that specifically bind to an avian e. coli iss polypeptide.
02/13/2001US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication.
02/13/2001US6187319 Administering to the animal an isolated vp6 polypeptide of a second rotavirus sufficient to produce an effective immune response against the first rotavirus, the second rotavirus capable of infecting a different species than the first
02/13/2001US6187312 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases
02/13/2001US6187311 Engineered acarid allergen and process for producing the same
02/13/2001US6187308 Ameliorating an immune response disorder.
02/13/2001CA2208745C Adsorbent for endotoxin, tumor necrosis factor-.alpha. or interleukins, process for adsorbing and removing the same, and adsorber for the same
02/13/2001CA2173453C Cloned pullulanase
02/13/2001CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
02/13/2001CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof
02/13/2001CA2079230C Bcrf1 antagonists for treating epstein-barr virus infections
02/13/2001CA2067653C Modified complement system regulator
02/13/2001CA2067224C Hirudin/polyalkylene glycol conjugates
02/13/2001CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
02/10/2001WO2001032871A2 Follistatin-related protein zfsta4
02/10/2001CA2389956A1 Follistatin-related protein zfsta4
02/08/2001WO2001009390A1 Tenascin-c nucleic acid ligands
02/08/2001WO2001009382A1 Antibiotics based upon bacteriophage lysis proteins
02/08/2001WO2001009368A1 Follistatin antagonists
02/08/2001WO2001009360A1 USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR (rAAV) FOR THE PREVENTION OF SMOOTH MUSCLE CELL PROLIFERATION IN A VASCULAR GRAFT
02/08/2001WO2001009356A1 Mutant gene of the gras family and plants with reduced development containing said mutant gene
02/08/2001WO2001009355A2 PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF
02/08/2001WO2001009354A1 Herbicide resistant transgenic plants with mutated alpha-tubulin
02/08/2001WO2001009350A2 Genetically engineered bleb vaccine
02/08/2001WO2001009349A1 Gene encoding novel serine protease-like protein
02/08/2001WO2001009347A2 Archaeal replication accessory factors and methods of use
02/08/2001WO2001009346A1 Gene encoding novel adenylate kinase 3 (ak3)-like protein
02/08/2001WO2001009345A1 Novel genes encoding protein kinase/protein phosphatase
02/08/2001WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof
02/08/2001WO2001009339A2 Moraxella catarrhalis antigen basb117
02/08/2001WO2001009338A1 Basb116 dna and proteins from moraxella catarrhalis
02/08/2001WO2001009337A2 Moraxella catarrhalis antigens basb122 and basb124
02/08/2001WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009335A2 Moraxella catarrhalis antigen basb120
02/08/2001WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009333A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
02/08/2001WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
02/08/2001WO2001009331A2 Moraxella catarrhalis antigen basb125
02/08/2001WO2001009330A2 Moraxella catarrhalis antigen basb121
02/08/2001WO2001009329A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
02/08/2001WO2001009327A2 Method of preventing the injury or death of retinal cells and treating ocular diseases
02/08/2001WO2001009326A1 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes
02/08/2001WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
02/08/2001WO2001009324A1 Gene of human brain type pgt
02/08/2001WO2001009323A1 Guanosine triphosphate binding protein-coupled receptors, genes thereof and production and use of the same
02/08/2001WO2001009322A1 Guanosine triphosphate-binding protein coupled receptors, genes thereof and production and use of the same
02/08/2001WO2001009321A1 Gene encoding novel tsp1-like protein
02/08/2001WO2001009320A1 Gene encoding novel adp-ribosylation factor (arf)-like protein
02/08/2001WO2001009319A1 Gene expressed specifically in human fetal heart muscle
02/08/2001WO2001009318A1 Liver cancer-associated genes
02/08/2001WO2001009317A1 Stomach cancer-associated gene
02/08/2001WO2001009316A1 Novel genes encoding protein kinase/protein phosphatase
02/08/2001WO2001009315A1 Novel gene participating in the maintenance of smooth muscle cell differentiation
02/08/2001WO2001009314A1 Novel uses of abca-type transporters
02/08/2001WO2001009313A1 G-protein coupled receptor and dna sequences thereof
02/08/2001WO2001009309A2 RESCUE OF MUMPS VIRUS FROM cDNA
02/08/2001WO2001009308A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
02/08/2001WO2001009305A2 Purine metabolism genes in plants
02/08/2001WO2001009303A2 Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER
02/08/2001WO2001009301A2 Nucleic acids and polypeptides of invertebrate twik channels and methods of use
02/08/2001WO2001009300A2 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants
02/08/2001WO2001009291A1 Attenuated influenza virus useful as vaccine
02/08/2001WO2001009290A2 Avian infectious bronchitis virus serotype
02/08/2001WO2001009283A2 Chimeric receptors and their uses
02/08/2001WO2001009194A1 Recombinant proteins and molecular complexes derived therefrom, analogous to molecules involved in immune responses
02/08/2001WO2001009193A1 Chimeric polypeptides, method for production and uses thereof
02/08/2001WO2001009189A2 Compositions and methods for the treatment of tumors
02/08/2001WO2001009187A2 Human monoclonal antibodies to her2/neu
02/08/2001WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents
02/08/2001WO2001009185A2 Transmembrane transport proteins, nucleic acids encoding them and uses therefor
02/08/2001WO2001009184A1 Human g-protein coupled receptor
02/08/2001WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof
02/08/2001WO2001009182A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain
02/08/2001WO2001009181A1 Molecular motor
02/08/2001WO2001009180A1 Creating novel biosensors from natural biological receptors
02/08/2001WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof
02/08/2001WO2001009178A2 Human chaperone proteins
02/08/2001WO2001009177A2 Affinity fluorescent proteins and uses thereof
02/08/2001WO2001009176A2 Mammalian cytokines; related reagents
02/08/2001WO2001009175A2 Plant defensin variants with modified cystein residues
02/08/2001WO2001009174A2 Plant defensin variants
02/08/2001WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands
02/08/2001WO2001009172A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
02/08/2001WO2001009171A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
02/08/2001WO2001009170A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app)
02/08/2001WO2001009166A1 Octoray, a g-protein coupled receptor
02/08/2001WO2001009165A2 ACTIVATION OF PEPTIDE PRODRUGS BY hK2
02/08/2001WO2001009163A2 Improvement of peptide transport by conjugation with bile acids